Cargando…
Dopamine-receptor blocking agent-associated akathisia: a summary of current understanding and proposal for a rational approach to treatment
Dopamine-receptor blocking agent-associated akathisia (DRBA-A) is an adverse effect that can significantly limit the use of these important medications for the treatment of a variety of psychiatric diseases, yet there is no unifying theory regarding its pathophysiology. This knowledge gap limits cli...
Autores principales: | Musco, Shaina, McAllister, Vivian, Caudle, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457694/ https://www.ncbi.nlm.nih.gov/pubmed/32922732 http://dx.doi.org/10.1177/2045125320937575 |
Ejemplares similares
-
Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy
por: Musco, Shaina, et al.
Publicado: (2019) -
Mirtazapine Induced Akathisia: Understanding a Complex Mechanism
por: Raveendranathan, Dhanya, et al.
Publicado: (2015) -
Metoclopramide-induced akathisia
por: Chauhan, Gaurav, et al.
Publicado: (2012) -
Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges
por: Salem, Haitham, et al.
Publicado: (2017) -
FLUOXETINE INDUCED AKATHISIA AND SUICIDALLY
por: Pandey, S.K.
Publicado: (1999)